Medical management after index event at interview: EUROASPIRE III
Men | Women | p Value* | |
Cardiac rehabilitation attendance† | 34.9 | 31.0 | 0.002 |
Advice given to current smokers | |||
Verbal | 91.3 | 87.7 | 0.10 |
Written | 34.3 | 36.7 | 0.83 |
Clinic | 14.1 | 15.4 | 0.67 |
Smoking among former smokers | 51.9 | 51.9 | 0.91 |
Action taken to control excess body weight | |||
Following dietary advice | 50.3 | 55.1 | 0.04 |
Regular physical activity | 40.3 | 33.8 | 0.01 |
Weight reduction drugs | 1.8 | 2.3 | 0.31 |
None | 39.2 | 39.5 | 0.59 |
Hypertension | |||
Use of antihypertensive drugs | 66.8 | 80.1 | <0.0001 |
Raised blood pressure‡ in treated patients§ | 61.3 | 66.1 | 0.004 |
Raised blood pressure‡ in treated patients¶ | 54.4 | 61.0 | <0.0001 |
Dyslipidaemia | |||
Lipid lowering drug use | 80.4 | 77.9 | 0.83 |
LDL ≥ 2.5 mmol/l in treated patients | 46.3 | 54.8 | <0.0001 |
Diabetes | |||
Use of pharmacological treatment | 17.3 | 22.8 | <0.0001 |
Glucose ≥7 mmol/l in treated patients | 78.1 | 74.4 | 0.35 |
HbA1c ≥7% in treated patients | 49.6 | 63.0 | <0.0001 |
Results are shown as percentages.
↵* Significance between sexes adjusted for age and centre.
↵† attending at least half of the sessions.
↵‡ BP≥140/90 or BP≥130/80 mm Hg for diabetic patients or treatment.
↵§ In patients treated with antihypertensive drugs.
↵¶ In patients treated with any drug which may lower blood pressure (but not specifically prescribed for this reason).